2 Paul Tudor Jones II Orchard Therapeutics plc Trades
Paul Tudor Jones II started to build up the position in Orchard Therapeutics plc in Q4 2023. Since then they sold 300 Thousand shares. The investor sold all their shares in Q1 2024 and doesn't own any shares in Orchard Therapeutics plc anymore.
Avg closing price
Price range
Sold -300 Thousand shares
Q1 2024
Avg closing price
$16.48
Price range
$16.40
-
$16.70
New holding (+300 Thousand shares)
Q4 2023
Avg closing price
$15.75
Price range
$8.14
-
$16.47
News about Orchard Therapeutics plc - ADR and Paul Tudor Jones II
Orchard Therapeutics Announces Promising Early Neurocognitive Outcomes from Ongoing Proof-of-concept Study of OTL-201 in MPS-IIIA
All patients achieved sustained engraftment and supraphysiological SGSH enzyme levels with median 1.5 years follow-up
Orchard Therapeutics Announces First Neurocognitive Data from OTL-201 Study in MPS-IIIA Accepted for Oral Presentation at ASH 2022
Company to host KOL conference call and webcast on Monday, December 12 at 5:00 p.m. EST Company to host KOL conference call and webcast on Monday, December 1...